Multimodal Brain Monitoring May Improve ICU Outcomes - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Multimodal Brain Monitoring May Improve ICU Outcomes

Integrated neuromonitoring approaches may help identify neurologic complications earlier in patients admitted to ICU.

  • By

  • Andrea Surnit

  • May 7, 2026

  • 3 min

Share

  • 1

    Advanced neuromonitoring approaches may enhance detection of neurologic complications in ICU patients compared to standard clinical examinations.

  • 2

    Continuous electroencephalography (EEG) is crucial for identifying seizures in comatose patients, with up to 40% having nonconvulsive status epilepticus.

  • 3

    Multimodal neuromonitoring integrating various data types is recommended, as no single modality captures the full range of neurologic changes.

  • 4

    Automated pupillometry offers more accurate assessments of pupillary responses and strong prognostic accuracy in hypoxic ischemic brain injury.

  • 5

    Limitations in the evidence base include a focus on primary neurologic injury and the need for specialized expertise for neuromonitoring tools.

Original Source(s)

Multimodal Brain Monitoring May Improve ICU Outcomes

  • by Andrea Surnit

  • May 7, 2026

Related Content

International Consensus on the Evaluation and Management of : Results From a Modified Delphi Survey

Hypothalamic hamartomas (HH) are rare developmental brain lesions frequently associated with medically refractory epilepsy and complex neurobehavioral, cognitive and endocrine comorbidities.

  • by

  • August 14, 2026

  • 2 min
CREST-2 Findings Highlight Evolving Role of Carotid Artery Stenting

New findings from CREST-2 are providing important evidence on the role of carotid artery stenting (CAS) in patients with severe asymptomatic carotid stenosis — while underscoring the importance of operator experience, patient selection and procedural technique in achieving favorable outcomes.

  • by

  • September 14, 2026

  • 5 min
Prucalopride may enhance cognitive performance in remitted depression

Short‐term treatment improved verbal learning, working‐memory speed, and facial‐expression recognition vs placebo in a randomized trial.